North Tide Capital as of March 31, 2017
Portfolio Holdings for North Tide Capital
North Tide Capital holds 16 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Health Care SPDR (XLV) | 19.4 | $126M | 1.7M | 74.36 | |
| Select Medical Holdings Corporation (SEM) | 11.7 | $76M | 5.7M | 13.35 | |
| Tivity Health | 11.2 | $73M | 2.5M | 29.10 | |
| Gilead Sciences (GILD) | 10.4 | $68M | 1.0M | 67.92 | |
| Endo International | 7.7 | $50M | 4.5M | 11.16 | |
| Perrigo Company (PRGO) | 6.1 | $40M | 600k | 66.39 | |
| Mylan Nv | 6.0 | $39M | 1.0M | 38.99 | |
| Supervalu | 5.9 | $39M | 10M | 3.86 | |
| Impax Laboratories | 5.8 | $38M | 3.0M | 12.65 | |
| Tenet Healthcare Corporation (THC) | 5.4 | $35M | 2.0M | 17.71 | |
| Syneron Medical Ltd ord | 4.9 | $32M | 3.0M | 10.55 | |
| Horizon Pharma | 1.6 | $10M | 693k | 14.78 | |
| Vivus | 1.6 | $10M | 9.0M | 1.12 | |
| Quorum Health | 1.3 | $8.7M | 1.6M | 5.44 | |
| BioScrip | 0.8 | $5.1M | 3.0M | 1.70 | |
| Accuray Incorporated (ARAY) | 0.1 | $734k | 155k | 4.75 |
